Jonathan Kurman (@jonathankurman) 's Twitter Profile
Jonathan Kurman

@jonathankurman

Director of Interventional Pulmonology at Froedtert & the Medical College of Wisconsin

ID: 100006274

calendar_today28-12-2009 17:49:04

23 Tweet

110 Takipçi

31 Takip Edilen

Level Ex (@levelex) 's Twitter Profile Photo

We’re looking for interventional #cardiologists to provide feedback on our medical video games in various stages of development. No technical expertise required & only 1 hour of your time is needed. If interested, follow this link to sign up! levelex.typeform.com/to/lJGtkR

We’re looking for interventional #cardiologists to provide feedback on our medical video games in various stages of development. No technical expertise required & only 1 hour of your time is needed. If interested, follow this link to sign up! levelex.typeform.com/to/lJGtkR
Jonathan Kurman (@jonathankurman) 's Twitter Profile Photo

cbs58.com/news/persistan… Teamwork at its finest. This outcome would not have been possible without the unwavering support of my Froedtert & MCW interventional pulmonology team, my cardiothoracic surgery & anesthesia colleagues, and my mentors at the University of Chicago.

my_lungs (@my_lungs) 's Twitter Profile Photo

Congrats to Dr. Kurman and the interventional pulmonary team at @ Froedtert Hospital in Milwaukee Wisconsin for treating their 1st patient with the Zephyr Valves, a less-invasive treatment option for #COPD / Emphysema! For appointments:414-209-4404.

Congrats to Dr. Kurman and the interventional pulmonary team at @ Froedtert Hospital in Milwaukee Wisconsin for treating their 1st patient with the Zephyr Valves, a less-invasive treatment option for #COPD / Emphysema! For appointments:414-209-4404.
Laura Frye (@laurafryedrl) 's Twitter Profile Photo

Just a few spots left! This one-day hands-on cadaver program addresses chest tube placement, foreign body removal, the management of massive hemoptysis, and perc trach placement. AB Alraiyes S Faiz Jonathan Kurman CHEST #ChestIP #MedEd

Just a few spots left!  This one-day hands-on cadaver program addresses chest tube placement, foreign body removal, the management of massive hemoptysis, and perc trach placement.  <a href="/ahalraiyes/">AB Alraiyes</a> <a href="/sfaiz212/">S Faiz</a> <a href="/jonathankurman/">Jonathan Kurman</a> <a href="/accpchest/">CHEST</a> #ChestIP #MedEd
AME (@officeame) 's Twitter Profile Photo

Series on "Interventional Pulmonology in the Intensive Care Unit" is published on Journal of Thoracic Disease (IF: 2.895): jtd.amegroups.com/post/view/inte… Edited by Jonathan S. Kurman Jonathan Kurman, Rahul Nanchal Rahul Nanchal and Ashutosh Sachdeva ashutosh sachdeva. #JTD

Series on "Interventional Pulmonology in the Intensive Care Unit" is published on Journal of Thoracic Disease (IF: 2.895): jtd.amegroups.com/post/view/inte…

Edited by Jonathan S. Kurman <a href="/jonathankurman/">Jonathan Kurman</a>, Rahul Nanchal <a href="/NanchalRahul/">Rahul Nanchal</a> and Ashutosh Sachdeva <a href="/ummcIPdoc/">ashutosh sachdeva</a>. #JTD
my_lungs (@my_lungs) 's Twitter Profile Photo

Jonathan Kurman speaking about the new Chartis VT20 feature and its potential to decrease the time needed to assess the collateral ventilation status of Zephyr Valve candidates during the Pulmonx-sponsored symposium at AABIP. #AABIP

<a href="/jonathankurman/">Jonathan Kurman</a>  speaking about the new Chartis VT20 feature and its potential to decrease the time needed to assess the collateral ventilation status of Zephyr Valve candidates during the Pulmonx-sponsored symposium at <a href="/AAB_IP/">AABIP</a>. #AABIP
Jonathan Kurman (@jonathankurman) 's Twitter Profile Photo

I performed a BLVR procedure using Zephyr Endobronchial Valves on a 65-year-old male with severe emphysema. Patient experienced FEV1 improvement from 24% to 31%. my_lungs See the full case here: pulmonx.com/65-year-old-ma… Drop me a comment if you have questions about the case.

I performed a BLVR procedure using Zephyr Endobronchial Valves on a 65-year-old male with severe emphysema. Patient experienced FEV1 improvement from 24% to 31%. <a href="/my_lungs/">my_lungs</a> 

See the full case here: pulmonx.com/65-year-old-ma…
 
Drop me a comment if you have questions about the case.
MCW IM Chief Residents (@mcw_medchiefs) 's Twitter Profile Photo

Senior academic half day this morning was 🔥🔥🔥 Thanks to Dr. Kurman Jonathan Kurman for talking with us about interventional pulm 🫁 and Dr. Mohananey Divyanshu Mohananey for talking with us about native mitral regurgitation 🫀 We have the coolest faculty 🫶🏻

Jonathan Kurman (@jonathankurman) 's Twitter Profile Photo

Honored to have our BLVR program featured in the Milwaukee Journal Sentinel & USA Today. Have helped nearly 100 patients with emphysema breathe better. #emphysema #Froedtert #Pulmonx #COPD #GOLDguidelines #Zephyr #endobronchialvalves jsonline.com/story/news/hea…

my_lungs (@my_lungs) 's Twitter Profile Photo

TODAY: Hear Pulmonologists Dr. MeiLan Han, Dr. Jonathan Kurman & Dr. Ralitza Martin discuss Endobronchial Valves, a Standard of Care Treatment Option for severe #COPD/#Emphysema. bit.ly/3qLiI1g Pulmonx Corporation, Maker of the Zephyr Valve, is sponsoring the event.

TODAY: Hear Pulmonologists Dr. <a href="/meilan_han/">MeiLan Han</a>, Dr. <a href="/jonathankurman/">Jonathan Kurman</a> &amp; Dr. Ralitza Martin discuss Endobronchial Valves, a Standard of Care Treatment Option for severe #COPD/#Emphysema. 

bit.ly/3qLiI1g

Pulmonx Corporation, Maker of the Zephyr Valve, is sponsoring the event.
SAB (@sabronchoscopy) 's Twitter Profile Photo

See you TONIGHT at 7:00pm ET for our live sponsored webinar event, "Single-Use Bronchoscopes: Ready for Prime Time." Jonathan Kurman REGISTER TODAY! >>> tinyurl.com/573nyu7w #SAB #Educate #Innovate #Empower #pulmonology #bronchoscopy Ambu USA

See you TONIGHT at 7:00pm ET for our live sponsored webinar event, "Single-Use Bronchoscopes: Ready for Prime Time." <a href="/jonathankurman/">Jonathan Kurman</a> 
REGISTER TODAY! &gt;&gt;&gt; tinyurl.com/573nyu7w 
#SAB #Educate #Innovate #Empower #pulmonology #bronchoscopy <a href="/AmbuUSA/">Ambu USA</a>
SAB (@sabronchoscopy) 's Twitter Profile Photo

Check out the latest SAB Sponsored Webinar RECORDING! Jonathan Kurman WATCH NOW >>tinyurl.com/ycxahkkr Not a SAB member? Join today! >> tinyurl.com/2j79ftub #SAB #Educate #Innovate #Empower #bronchoscopy #pulmonology Ambu USA

Check out the latest SAB Sponsored Webinar RECORDING! <a href="/jonathankurman/">Jonathan Kurman</a> 
WATCH NOW &gt;&gt;tinyurl.com/ycxahkkr
Not a SAB member? Join today! &gt;&gt; tinyurl.com/2j79ftub
#SAB #Educate #Innovate #Empower #bronchoscopy #pulmonology <a href="/AmbuUSA/">Ambu USA</a>
Ambu USA (@ambuusa) 's Twitter Profile Photo

“The degree of flexion that you get with and without a tool in the channel with the new single use flexible bronchoscopes is pretty incredible.” –Dr. Jonathan Kurman Take our aScope™ 5 Bronchoscope Bending Challenge for yourself! ow.ly/AeXx50PkSfj #AABIP #AABIP2023

CHEST (@accpchest) 's Twitter Profile Photo

Attend CHEST's new hands-on, expert-led course and enhance your skills in bronchoscopic lung volume reduction candidate assessment, persistent air leak management, and target lobe identification. Register now: hubs.la/Q02gQ2bM0

Attend CHEST's new hands-on, expert-led course and enhance your skills in bronchoscopic lung volume reduction candidate assessment, persistent air leak management, and target lobe identification. Register now: hubs.la/Q02gQ2bM0
Interventional Pulmonary Outcomes Group (@ipulmog) 's Twitter Profile Photo

Very excited to share the results from the VERITAS trial presented by Dr. Lentz here ATS TO Assembly #ATS2024. Bottom line is there is a 98+% likelihood that #NavigationalBronchoscopy is non-inferior to CT-guided Transthoracic biopsy and significantly safer. Full data to come!

Very excited to share the results from the VERITAS trial presented by Dr. Lentz here <a href="/atstoa/">ATS TO Assembly</a> #ATS2024. Bottom line is there is a 98+% likelihood that #NavigationalBronchoscopy is non-inferior to CT-guided Transthoracic biopsy and significantly safer. Full data to come!